Zoe Arvanitakis to Follow-Up Studies
This is a "connection" page, showing publications Zoe Arvanitakis has written about Follow-Up Studies.
Connection Strength
0.541
-
Antiphospholipid Antibodies: Cognitive and Motor Decline, Neuroimaging and Neuropathology. Neuroepidemiology. 2019; 53(1-2):100-107.
Score: 0.117
-
Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology. Neurology. 2018 08 07; 91(6):e517-e525.
Score: 0.110
-
The Relationship of Cerebral Vessel Pathology to Brain Microinfarcts. Brain Pathol. 2017 01; 27(1):77-85.
Score: 0.094
-
Microinfarct pathology, dementia, and cognitive systems. Stroke. 2011 Mar; 42(3):722-7.
Score: 0.066
-
Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology. 2008 Jun 03; 70(23):2219-25.
Score: 0.055
-
Is Midlife Metabolic Syndrome Associated With Cognitive Function Change? The Study of Women's Health Across the Nation. J Clin Endocrinol Metab. 2020 04 01; 105(4).
Score: 0.031
-
Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology. J Alzheimers Dis. 2017; 56(2):699-706.
Score: 0.025
-
Cognitive decline following incident and preexisting diabetes mellitus in a population sample. Neurology. 2016 Oct 18; 87(16):1681-1687.
Score: 0.024
-
Apolipoprotein E and change in episodic memory in blacks and whites. Neuroepidemiology. 2013; 40(3):211-9.
Score: 0.019